Search

The Genetics Society of America medal honored Dr. Anderson, Chair of the Developmental Biology Program, for her lifetime contributions to the science of genetics.

… Wednesday, June 6, 2012 Summary The Genetics Society of America medal honored Dr. Anderson, Chair of the Developmental Biology Program, for her lifetime contributions to the science of genetics. Kathryn V. Anderson , Chair of the Developmental Biology Program in the Sloan Kettering Institute , was named

Kenneth Manotti has been named Senior Vice President and Chief Development Officer at Memorial Sloan Kettering Cancer Center (MSK).

… Wednesday, July 25, 2018 Kenneth Manotti has been named Senior Vice President and Chief Development Officer at Memorial Sloan Kettering Cancer Center (MSK). Mr. Manotti has more than 30 years of fundraising and leadership experience at major institutions, including the University of Pennsylvania, Columbia

Learn about how cognitive behavioral therapy for insomnia (CBT-I) helps people with cancer improve sleep.

… Monday, May 9, 2022 Memorial Sloan Kettering Integrative Medicine Service sleep therapist Eugenia Spiguel Eugenie Spiguel As if having cancer wasn’t hard enough, up to 50% of patients and survivors also suffer from insomnia or other sleep disturbances, says Eugenie Spiguel , an advanced practice provider

Learn about a new vaccine at MSK that could prevent neuroblastoma from returning after treatment.

… Wednesday, September 10, 2025 Emily faced one harrowing decision after another. Her 4-year-old son, James, had been diagnosed with stage 4 high-risk neuroblastoma, a rare cancer of nerve cells. James immediately began chemotherapy at a hospital in the Washington, D.C., area, where they lived. Within

Developed by scientists at MSK and the University of British Columbia/BC Cancer, the platform provides the deepest look yet into tumor evolution.

… Thursday, November 14, 2019 VIDEO | 00:42 DLP+ in action: A liquid suspension of single cells in a glass pipette moves in front a camera linked to a microscope. When a cell is detected in the suspension, the machine moves to the right and deposits the cell on a microchip for DNA sequencing. Video courtesy

A preclinical study published in the journal Molecular Therapy by researchers at Memorial Sloan Kettering (MSK) provides evidence that radiation therapy could improve the efficacy of CAR T cell therapy for solid tumors.

… Thursday, October 25, 2018 Background: A preclinical study published in the journal Molecular Therapy by researchers at Memorial Sloan Kettering (MSK) provides evidence that radiation therapy could improve the efficacy of CAR T cell therapy for solid tumors. The success of chimeric antigen receptor (

The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomed its ninth class of PhD students on July 21, 2014.

… Monday, August 25, 2014 The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomed its ninth class of PhD students on July 21, 2014. The nine students are Steven Albanese, Jacob A. Boyer, Christopher Hulton, Nayan Jain, Nicholas F. Kuhn, Xiaoyi Li, Michelle M.E. Riegman, Benjamin Y.

MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of their treatment offers them a better chance of being cured.

… Friday, January 17, 2025 When Aaron von Freter learned he had  chronic myeloid leukemia (CML) , he “felt like the room was spinning,” he remembers. “I thought I’d been served a death sentence.” Aaron was 45 years old and had no symptoms. His CML diagnosis came after standard bloodwork revealed an extremely

Third-year students Oakley Olsen and Alison Spencer have been named Grayer Fellows. Fellows are chosen based on excellence demonstrated by their thesis proposal examinations.

… Monday, October 10, 2011 Third-year students Oakley Olsen and Alison Spencer have been named Grayer Fellows. These fellowships were established by Mr. and Mrs. Jonathan Grayer. Mr. Grayer is a member of the Gerstner Sloan Kettering Board of Trustees and the former chairman and CEO of Kaplan, Inc., which

Former leader of Memorial Sloan Kettering Paul Marks gives a compelling view of cancer research and treatment over the past 40 years in On the Cancer Frontier: One Man, One Disease, and a Medical Revolution.

… Wednesday, April 16, 2014 Summary Former leader of Memorial Sloan Kettering Paul Marks gives a compelling view of cancer research and treatment over the past 40 years in On the Cancer Frontier: One Man, One Disease, and a Medical Revolution . Paul Marks — who served as President and Chief Executive Officer